NLC The European Healthtech Venture Builder has closed Momentum – a € 2.2 mln fund for private investments -within a month. This fund will be invested in 11 innovative healthtech ventures from NLC’s portfolio. With this new way of funding, investors can easily spread their money and hence their risk, and at the same time build up a broad portfolio of startups.
Considering the short timeframe in which the € 2.2 mln fund was closed, Momentum’s approach seems to be a successful new way of attracting financing for startups. This form of financing offers a solution for the lack of capital funding that start-ups often encounter in the ‘pre-seed’ and ‘seed’ phase of financing. Although the total amount of investment in healthcare is increasing, there appears to be a shift towards investing in ventures that are well past the ‘pre-seed’ and ‘seed’ stages. This results in a structural shortage in capital for early-stage startups.
MLA Diagnostics CEO, Egbert Smit -“Momentum is a great initiative by NLC to help startups at an early stage in their existence. This funding will help MLA Diagnostics to further validate the assay in patient samples to bring us closer to CE mark.”
